Healthtech

Practo Appoints Former Union Health Secretary CK Mishra to Board as India Healthtech Giants Gear Up for IPO Wave

IPO-bound Practo strengthens its board with ex-health secretary CK Mishra as India's healthtech sector prepares for a wave of public listings in 2026.
IPO-bound Practo strengthens its board with ex-health secretary CK Mishra as India's healthtech sect

Digital healthcare platform Practo has appointed former Union Health Secretary CK Mishra to its board as an independent director, the Bengaluru-based company announced on 11 March 2026. The appointment strengthens Practo’s governance structure as it expands global operations and prepares for what industry analysts expect to be a public listing in the near term.

Who Is CK Mishra

An Indian Administrative Service (IAS) officer with 37 years of public sector experience, Mishra retired in 2020 after holding senior leadership roles across health, environment, education, industry, and power. As health secretary, he played a central role in managing one of the world’s largest public health ecosystems, overseeing policy during critical periods for India’s healthcare infrastructure.

“It is an honour for us that CK Mishra has chosen to join Practo’s board and, notably, make this his first such association with a company in the healthcare space,” Practo founder and CEO Shashank ND said. “In a sector where trust is paramount, neutrality becomes critical infrastructure, and his guidance will help us deepen that trust as we scale.”

Practo’s Growth Trajectory

Practo operates a two-sided healthcare marketplace connecting patients with doctors, hospitals, and diagnostic centres. The platform claims over 200,000 doctors and 8,000 hospitals across India on its network. The company has expanded beyond India into the United States, UAE, Singapore, and other markets, scaling both its consumer search platform and its enterprise software product, Practo Ray.

The board-level addition of a former health secretary signals intent to institutional investors and regulators ahead of a potential IPO. India’s technology sector has seen a renewed appetite for public listings in 2026, and healthtech companies are among the most closely watched.

India’s Healthtech Ecosystem in 2026

Practo’s move reflects a broader maturation of India’s healthtech sector. Other notable developments this year include:

  • Plazza, a quick medicine delivery startup, is in talks to raise approximately $6 million, highlighting investor interest in pharmaceutical logistics.
  • Even Healthcare has expanded into Bengaluru with its second hospital, pioneering an integrated care model.
  • The AIIMS-led AI healthcare initiatives demonstrated at World Health Day 2026 have set new benchmarks for technology integration in public health.

Why Board Governance Matters for Healthtech IPOs

Investors evaluating healthtech IPOs pay close attention to board composition, particularly in a sector where regulatory compliance and public trust are paramount. Mishra’s appointment adds credibility on both fronts. His experience navigating government health policy will be valuable as Practo scales across markets with different regulatory frameworks.

What to Watch

The healthtech IPO pipeline in India is expected to include several companies that raised large private rounds during the 2020–2022 funding boom. While some, like PharmEasy, have faced down rounds and restructuring, others such as Practo appear to have maintained stronger unit economics and clearer paths to profitability.

With fresh capital flowing into Indian startups and public market appetite recovering, 2026 could mark the year India’s healthtech sector transitions from venture-backed growth to public market accountability.

Anjali K.

Anjali K.

Anjali K. is a Senior Writer at Daily Tips specialising in health, nutrition, regional cuisine, and cultural reporting. Her writing draws on extensive research and first-hand reporting — whether she's exploring the revival of millets in Indian diets or documenting the food traditions of Northeast India. Anjali holds a background in nutrition science and brings an evidence-based approach to her health and wellness coverage.

View all posts by Anjali K. →